Press Releases September 10, 2026 09:00 AM

Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company

Precision Optics Secures $1.3 Million Follow-On Orders from Major U.S. Defense Contractor, Setting Stage for Long-Term Production Agreement

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
POCI

Precision Optics Corporation announced receipt of $1.3 million in follow-on production orders from a large U.S. defense contractor for advanced optical assemblies. The program, in production since 2018, could continue for at least ten years with upcoming negotiations for a long-term manufacturing agreement aimed at improving production continuity and cost efficiencies. This ensures a steady business foundation in defense and aerospace markets and highlights Precision Optics' role as a valued supplier.

Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company
POCI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Received $1.3 million in follow-on production orders from a major U.S. defense contractor supporting a long-running program since 2018.
  • Potential for a decade-long production run with planned negotiations for a structured long-term manufacturing agreement to smooth production cadence and reduce order gaps.
  • Precision Optics leverages vertically integrated U.S.-based manufacturing to provide advanced micro-optical components for defense, aerospace, and medical sectors, emphasizing size, weight, reliability, and performance.
  • Impacted sectors include defense and aerospace manufacturing, advanced optics technology, and supply chains for military hardware production.

LITTLETON, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced the receipt of follow-on production orders totaling approximately $1.3 million from a large U.S. defense contractor. The order supports continued production of highly complex optical assemblies developed jointly with the customer and manufactured by Precision Optics since 2018.

Precision Optics believes the program has the potential to remain in production for at least the next ten years. The Company and its customer expect to negotiate a long-term manufacturing agreement in the coming months with provisions for a structured order framework designed to reduce order gaps and support a more continuous manufacturing cadence. The agreement is expected to benefit both parties by preserving manufacturing continuity and knowledge base, improving planning and throughput, and generating greater cost efficiencies.

“This $1.3 million order represents the next phase of an established program,” said Joseph Forkey, CEO of Precision Optics. “The intention of our customer to work toward an ongoing order structure reflects confirmation that the component we provide is a critical element of their long-term strategic planning and that POC is a valued supplier. It also provides a strong base of continuous business for our micro-optics group, serving as a platform to pursue additional opportunities in the defense and aerospace market.”

Precision Optics provides advanced micro-optical components and assemblies for a range of defense and aerospace applications, including applications in which size, weight, reliability and performance are critical to mission success. The Company’s vertically integrated, U.S.-based manufacturing capabilities allow it to work with customers from initial product design and engineering through qualification and recurring production.

About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.

About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

Company Contact:                                         
PRECISION OPTICS CORPORATION
550 King Street, Building A, Suite 100
Littleton, MA 01460
Telephone: 978-630-1800

Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
[email protected]


Risks

  • Dependence on continued demand from large defense contractor; any changes in their strategic priorities could reduce orders or delay agreements.
  • Supply chain uncertainties and global economic conditions may impact manufacturing throughput and cost efficiencies.
  • Forward-looking statements may not materialize as planned; risks include fluctuating demand, possible contract negotiation challenges, and operational execution risks affecting production continuity.

More from Press Releases

IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001 Sep 10, 2026 BOS to Release Third Quarter 2026 Results on November 30, 2026 Sep 10, 2026 Gix Internet Launches New Corporate Website Presenting Its Vision for One Intelligent Management Layer for Robots, People and Autonomous Systems Sep 10, 2026 Imperial Petroleum Inc. Reports Second Quarter and Six Months 2026 Financial and Operating Results Sep 10, 2026 TEN, Ltd. Reports Profits for the First Half and Second Quarter of 2026 Sep 10, 2026